Comorbidity is an independent prognostic factor in women with uterine corpus cancer: a nationwide cohort study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Comorbidity is an independent prognostic factor in women with uterine corpus cancer : a nationwide cohort study. / Noer, Mette C; Sperling, Cecilie; Christensen, Ib J; Nielsen, Marie L S; Lidegaard, Ojvind; Høgdall, Claus.
I: Acta Obstetrica et Gynecologica, Bind 93, Nr. 4, 04.2014, s. 325-334.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Comorbidity is an independent prognostic factor in women with uterine corpus cancer
T2 - a nationwide cohort study
AU - Noer, Mette C
AU - Sperling, Cecilie
AU - Christensen, Ib J
AU - Nielsen, Marie L S
AU - Lidegaard, Ojvind
AU - Høgdall, Claus
N1 - © 2014 Nordic Federation of Societies of Obstetrics and Gynecology.
PY - 2014/4
Y1 - 2014/4
N2 - OBJECTIVE: To determine whether comorbidity independently affects overall survival in women with uterine corpus cancer.DESIGN: Cohort study.SETTING: Denmark.STUDY POPULATION: A total of 4244 patients registered in the Danish Gynecologic Cancer database with uterine corpus cancer from 1 January 2005 until 13 October 2011.METHODS: All patients included in the study were assigned a comorbidity score according to the Charlson Comorbidity Index. Multivariate survival analyses were performed to investigate the prognostic impact of comorbidity adjusting for known prognostic factors. As performance status might capture the prognostic impact of comorbidity and because information on the variable grade was missing in some special histological subtypes, we included different models in the multivariate analyses with and without PS and grade, respectively.MAIN OUTCOME MEASURES: Overall survival.RESULTS: Univariate survival analysis showed a significant (p < 0.001) negative association between increasing level of comorbidity and overall survival. Multivariate analyses adjusting for other prognostic factors showed that comorbidity is a significant independent prognostic factor with hazard ratios ranging from 1.27 to 1.42 in mild, 1.69 to 1.74 in moderate, and 1.72 to 2.48 in severe comorbidity. Performance status was independently associated to overall survival and was found to slightly reduce the prognostic impact of comorbidity.CONCLUSION: Comorbidity is an independent prognostic factor in uterine corpus cancer and increasing levels of comorbidity are associated with shorter survival.
AB - OBJECTIVE: To determine whether comorbidity independently affects overall survival in women with uterine corpus cancer.DESIGN: Cohort study.SETTING: Denmark.STUDY POPULATION: A total of 4244 patients registered in the Danish Gynecologic Cancer database with uterine corpus cancer from 1 January 2005 until 13 October 2011.METHODS: All patients included in the study were assigned a comorbidity score according to the Charlson Comorbidity Index. Multivariate survival analyses were performed to investigate the prognostic impact of comorbidity adjusting for known prognostic factors. As performance status might capture the prognostic impact of comorbidity and because information on the variable grade was missing in some special histological subtypes, we included different models in the multivariate analyses with and without PS and grade, respectively.MAIN OUTCOME MEASURES: Overall survival.RESULTS: Univariate survival analysis showed a significant (p < 0.001) negative association between increasing level of comorbidity and overall survival. Multivariate analyses adjusting for other prognostic factors showed that comorbidity is a significant independent prognostic factor with hazard ratios ranging from 1.27 to 1.42 in mild, 1.69 to 1.74 in moderate, and 1.72 to 2.48 in severe comorbidity. Performance status was independently associated to overall survival and was found to slightly reduce the prognostic impact of comorbidity.CONCLUSION: Comorbidity is an independent prognostic factor in uterine corpus cancer and increasing levels of comorbidity are associated with shorter survival.
KW - Adenocarcinoma
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Carcinoma
KW - Cohort Studies
KW - Comorbidity
KW - Denmark
KW - Female
KW - Humans
KW - Kaplan-Meier Estimate
KW - Middle Aged
KW - Neoplasm Grading
KW - Neoplasm Staging
KW - Neoplasm, Residual
KW - Predictive Value of Tests
KW - Prognosis
KW - Risk Factors
KW - Sarcoma
KW - Uterine Neoplasms
U2 - 10.1111/aogs.12338
DO - 10.1111/aogs.12338
M3 - Journal article
C2 - 24443826
VL - 93
SP - 325
EP - 334
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
SN - 0001-6349
IS - 4
ER -
ID: 138147851